Valeant Pharmaceuticals International Inc. remains “on the hunt for other companies, including makers of innovative contact lenses, as it presses on with efforts to take over Botox-maker Allergan Inc (AGN.N),” according to a Reuters report. “On a conference call with investors, Valeant Chief Executive Officer Michael Pearson said the company will not be content to remain the No. 4 global player in the contact lens industry.” Read more.
No comments:
Post a Comment